139 related articles for article (PubMed ID: 1415941)
1. Lipocortin-present perforating and lipocortin-absent nonperforating Crohn's disease.
Sakanoue Y; Horai T; Okamoto T; Hatada T; Shoji Y; Fujita S; Kusunoki M; Utsunomiya J
Am J Surg; 1992 Oct; 164(4):341-4. PubMed ID: 1415941
[TBL] [Abstract][Full Text] [Related]
2. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
3. Ileal and colonic fatty acid profiles in patients with active Crohn's disease.
Bühner S; Nagel E; Körber J; Vogelsang H; Linn T; Pichlmayr R
Gut; 1994 Oct; 35(10):1424-8. PubMed ID: 7959199
[TBL] [Abstract][Full Text] [Related]
4. Cytokines in Crohn's colitis.
Sher ME; D'Angelo AJ; Stein TA; Bailey B; Burns G; Wise L
Am J Surg; 1995 Jan; 169(1):133-6. PubMed ID: 7817982
[TBL] [Abstract][Full Text] [Related]
5. Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease.
Yamamoto T; Allan RN; Keighley MR
Dis Colon Rectum; 1999 Apr; 42(4):519-24. PubMed ID: 10215055
[TBL] [Abstract][Full Text] [Related]
6. Ileal and colonic mucosal bile acids in Crohn's disease and right colonic carcinoma.
Kurtz WJ; Leuschner U; Strohm WD; Classen M
Tokai J Exp Clin Med; 1985 Apr; 10(1):47-50. PubMed ID: 4095712
[TBL] [Abstract][Full Text] [Related]
7. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa.
Kald B; Olaison G; Sjödahl R; Tagesson C
Digestion; 1990; 46(4):199-204. PubMed ID: 2282995
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease.
Simillis C; Yamamoto T; Reese GE; Umegae S; Matsumoto K; Darzi AW; Tekkis PP
Am J Gastroenterol; 2008 Jan; 103(1):196-205. PubMed ID: 17900320
[TBL] [Abstract][Full Text] [Related]
9. Jejunal release of prostaglandin E2 in Crohn's disease: relation to disease activity and first-degree relatives.
Ahrenstedt O; Hällgren R; Knutson L
J Gastroenterol Hepatol; 1994; 9(6):539-43. PubMed ID: 7865710
[TBL] [Abstract][Full Text] [Related]
10. Surgical recurrence of perforating and nonperforating Crohn's disease. A study of 101 surgically treated Patients.
Aeberhard P; Berchtold W; Riedtmann HJ; Stadelmann G
Dis Colon Rectum; 1996 Jan; 39(1):80-7. PubMed ID: 8601362
[TBL] [Abstract][Full Text] [Related]
11. Perforating and nonperforating Crohn's disease. An unpredictable guide to recurrence after surgery.
McDonald PJ; Fazio VW; Farmer RG; Jagelman DG; Lavery IC; Ruderman WB; Easley KA; Harper PH
Dis Colon Rectum; 1989 Feb; 32(2):117-20. PubMed ID: 2914525
[TBL] [Abstract][Full Text] [Related]
12. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.
Lilja I; Smedh K; Olaison G; Sjödahl R; Tagesson C; Gustafson-Svärd C
Gut; 1995 Sep; 37(3):380-5. PubMed ID: 7590434
[TBL] [Abstract][Full Text] [Related]
14. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
15. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities in mucin gene expression in Crohn's disease.
Buisine MP; Desreumaux P; Debailleul V; Gambiez L; Geboes K; Ectors N; Delescaut MP; Degand P; Aubert JP; Colombel JF; Porchet N
Inflamm Bowel Dis; 1999 Feb; 5(1):24-32. PubMed ID: 10028446
[TBL] [Abstract][Full Text] [Related]
17. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.
Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH
Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
19. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease.
Wardle TD; Hall L; Turnberg LA
Gut; 1992 Dec; 33(12):1644-51. PubMed ID: 1487166
[TBL] [Abstract][Full Text] [Related]
20. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.
Mulder TP; Verspaget HW; Janssens AR; de Bruin PA; Peña AS; Lamers CB
Gut; 1991 Oct; 32(10):1146-50. PubMed ID: 1955169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
